Ledger.Open graph →
SEC Form D · filed September 20, 2021

Allay Therapeutics, Inc

Offering
$82.4M
Sold
$82.4M
Exemption
Rule 506(b)
Industry
Other Technology
Location
MENLO PARK, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (22)

Olin J. Utterback · New York, NYExec · DirectorMirza J. Galeano · New York, NYDirectorNathan A. Lutz · Uniontown, PADirectorRomain N. Delvert · Luxembourg, LuxembourgDirectorTak D. Cheung · Menlo Park, CADirectorMichael Vinci · Manhattan Beach, CADirectorTiffany Kosch · AUSTIN, TXDirectorMark A. Deem · Menlo Park, CADirectorPol-Henri N. Lebrun · Luxembourg, LuxembourgDirectorNicole J. Walker · Menlo Park, CADirectorLeighton D. Read · Menlo Park, CADirectorJosh D. Makower · Menlo Park, CADirectorNigel N. Williams · Luxembourg, LuxembourgExec · DirectorKathryn C. Leaf · San Francisco, CADirectorZachary K. Ellis · Pittsburgh, PADirectorPaul J. Mccreadie · Plymouth, MIDirectorAdam D. Gridley · Menlo Park, CAExec · DirectorNicole J. Walker · Chicago, ILDirectorAdel C. Alderbas · New York, NYDirectorMichael A. Carusi · Menlo Park, CADirectorPaul J. Mccreadie · Plymouth, MIDirectorJeremy Kranz · SAN FRANCISCO, CADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗